Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Enavatuzumab |
Trade Name | |
Synonyms | PDL 192 |
Drug Descriptions |
Enavatuzumab (PDL 192) is a monoclonal antibody against tumor necrosis factor-like weak inducer of apoptosis receptor (TWEAKR) that activates innate anti-tumor immune response (PMID: 29075649, PMID: 29054986). |
DrugClasses | |
CAS Registry Number | 1062149-33-0 |
NCIT ID | C80045 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Enavatuzumab | Enavatuzumab | 0 | 0 |